Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 72 (HNRNPA1P72) is a processed pseudogene—a non-protein-coding DNA sequence with high similarity to the parental HNRNPA1 gene, which encodes an RNA-binding protein involved in RNA metabolism, splicing, and transport[1][3][5]. Unlike its parental gene, HNRNPA1P72 does not code for a functional protein and is not considered a therapeutic target or receptor. Current data do not indicate a direct biological function or disease role for HNRNPA1P72; it is not implicated in drug targeting, disease biomarker usage, or therapeutic safety concerns, and its scientific relevance is limited to genomics and the study of pseudogenes[1][5]. Notes: - HNRNPA1P72 is a *pseudogene* and not a functional protein, receptor, enzyme, or therapeutic target[1][3][5]. - Most scientific and clinical interest in the family pertains to its functional parental gene, HNRNPA1, not HNRNPA1P72. - If searching for a therapeutic or diagnostic target, HNRNPA1 (not the pseudogene 72) is the relevant molecule[2][4]. - There are no recognized interacting drugs, mechanisms of action, biomarkers, associations with disease roles, or specific molecular functions assigned to this pseudogene[1][3][5]. If there are further needs for structured nomenclature or specificity about the parental gene, please clarify if you require data for **Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1)**, which is an active RNA-binding protein involved in various biological and pathological processes[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 72 (HNRNPA1P72).